Franklyn G Prendergast has an estimated net worth of $60.8 Million. This is based on reported shares across multiple companies, which include LILLY ELI & CO, Immunome Inc., NeuBase Therapeutics, Inc., Lantern Pharma Inc., and CANCER GENETICS, INC.
2017 was Franklyn G Prendergast's most active year for acquiring shares with 5 total transactions. Franklyn G Prendergast's most active month to acquire stocks was the month of October. 2023 saw Franklyn G Prendergast paying a total of $185,928.75 for 205,065 shares, this is the most they've acquired in one year.